SKSamantha Kaplan

Samantha Kaplan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Samantha Kaplan has a total of 199 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Financial Toxicity in Plastic Surgery

    by Josip Plascevic, Joey Liang, Sarah Ludington, Jimin Kim, Samantha Kaplan, Kristen Rezak, Ash Patel

    Introduction: Financial toxicity (FT) describes the physical, psychosocial, and financial burden of health care–related costs on patients’ well-being. Plastic surgery patients may be susceptible to FT due to high procedure and adjunct therapy costs. Despite these risks, FT resulting from plastic and reconstructive surgery remains unclear. This scoping review assessed the prevalence and impact of FT on plastic surgery patients. Methods: MEDLINE, Embase, Web of Science Core Collection, Scopus, and the Cumulative Index to Nursing and Allied Health Literature were searched from inception through February 17, 2026, for studies evaluating FT in plastic surgery. At least 2 reviewers independently screened records and performed data extraction. Findings were synthesized narratively. Reporting followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses–Extension for Scoping Reviews guidance. Results: Of the 4213 studies screened, 14 studies were included in the review. All included studies incorporated cross-sectional survey data, most commonly evaluating breast reconstruction (n = 8, 57.14%). Greater FT was most consistently associated with socioeconomic vulnerability, including lower household income and less favorable insurance or financial circumstances, while treatment-related associations varied across clinical contexts. FT was characterized by out-of-pocket expenses, financial decline, debt, employment-related consequences, and reductions in household spending. Greater FT was also associated with poorer psychosocial well-being, quality of life, and symptom burden. Coping behaviors included use of savings or credit, reductions in essential and nonessential spending, and changes in health care use or treatment timing. Conclusion: FT among patients receiving plastic surgical care extended beyond direct out-of-pocket expenses to broader financial and psychosocial consequences. Socioeconomic vulnerability was most consistently associated with greater FT, while treatment-related associations varied across clinical contexts. Future prospective studies should evaluate financial-needs screening, cost-informed counseling, and financial navigation as potential strategies to reduce FT and improve cost understanding and treatment decision-making.

  • The Impact of Social Support on Outcomes in Spine Surgery Patients

    by Jacqueline M. Emerson, Advika Kumar, Cristal Ortiz, Kristina N. Schaufele, Dana G. Rowe, Antoinette J. Charles, Edwin Owolo, Michael H. Weber, Raphaele Charest-Morin, Rafael De la Garza Ramos, et al.

    Study Design: Systematic review and meta-analysis. Objective: To perform a systematic review and meta-analysis of the impact of social support on outcomes among adults undergoing nontraumatic/nononcologic spine surgery. Summary of Background Data: Spine surgery patients experience perioperative physical discomfort and psychological stress linked to negative outcomes like persistent pain, prolonged hospital stays, and re-admission. While social support is known to improve postoperative outcomes, its role within spine surgery remains unclear. Methods: A systematic review was conducted in accordance with PRISMA guidelines. MEDLINE (PubMed), EMBASE (Elsevier), and Scopus (Elsevier) were searched from inception through October 2023. Keywords included adult spine surgery, prognosis, postoperative period, outcomes, and social support. The risk of bias was assessed using the Newcastle-Ottawa Scale. Data regarding social support and outcomes were collected. A meta-analysis was conducted to evaluate the association between social support and postoperative outcomes. Results: In summary, 982 full-text articles were screened, and 22 studies (11,702 patients) met the inclusion criteria. Samples ranged from 19–2070 patients (mean±SD: 532±562). The mean age was 55 years, and 52% were female. Half of the studies reported a significant positive association ( P OR =1.96, 95% CI: 1.28–3.00, I 2 =57%). Conclusions: Social support is a key predictor of clinical outcomes for spine surgery patients. While the types of social support reported in the literature were highly heterogeneous, patients with social support experienced shorter hospital stays, fewer readmissions, and increased home discharges. Enhancing perioperative resources for patients with limited social support networks may improve outcomes and enhance recovery for spine surgery patients. Level of Evidence: Level II.

  • Sex Disparities in Postoperative Outcomes Among Patients With Spine Tumors

    by Tobechukwu Ndika, Anushka Peer, Kristina Schaufele, Chinelo Agwuegbo, Seeley Yoo, Ellen O’CAllaghan, Alyssa Bartlett, Samantha Kaplan, Samantha Spellicy, Tara Dalton, et al.

    Objectives: Sex-based differences in postoperative outcomes have been reported in nononcologic spine surgery, but their impact among patients undergoing surgery for spine tumors remains poorly understood. We conducted a systematic review to evaluate the impact of patient sex on postoperative length of stay (LOS) and nonroutine discharge (NRD). Methods: A systematic literature search was performed according to PRISMA guidelines. Independent reviewers screened studies for eligibility. Studies were included if they evaluated adult patients undergoing spine tumor surgery and reported postoperative LOS and/or NRD stratified by patient sex. Study quality was assessed using the Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence and the Methodological Index for Non-Randomized Studies (MINORS). Results: Twelve retrospective cohort studies comprising 250,648 patients met the inclusion criteria. All studies were classified as moderate quality based on MINORS criteria. Nine studies evaluated LOS, with 3 demonstrating significant associations with patient sex. Two studies reported higher odds of prolonged LOS among female patients, whereas one reported higher odds among male patients. Nine studies evaluated NRD of which 4 found significantly higher odds of NRD among female patients, while 5 found no association. Conclusions: Evidence regarding sex-based differences in postoperative LOS and NRD was mixed, although female sex was more consistently associated with prolonged hospitalization and nonroutine discharge. These findings suggest that sex-based disparities in postoperative resource utilization may exist in spine oncology and should be considered in perioperative risk stratification and discharge planning.

  • The Relationship Between Anger and Nonsuicidal Self‐Injury: A Meta‐Analysis

    by Tate F. Halverson, Tapan A. Patel, Luke Nguyen, Rachel L. Zelkowitz, Molly Goodrich, Nathan A. Kimbrel, Samantha Kaplan, Kirsten H. Dillon

    Intro: Associations of negative affect and nonsuicidal self‐injury (NSSI) are well‐characterized. However, relationships between discrete negative emotions and NSSI are less well understood. An association between anger and NSSI is supported by contemporary models and growing evidence from studies across diverse populations. Methods: The goal of this meta‐analysis was to systematically review the literature and to calculate the effect size of the relationship between NSSI and anger. Results: The relationship between NSSI and anger constructs was examined with data from 25 studies (total N = 9148). Results of the meta‐analysis showed an overall moderate association between NSSI and anger (pooled Hedges' g = 0.55) based on 31 individual effect sizes. There were no significant differences in effect size estimates across anger constructs. There were no significant moderators of the relationship between NSSI and anger. Discussion: Findings highlight the important role of the discrete emotion of anger in NSSI among adults. Findings may inform clinical recommendations such as the assessment for potential NSSI when individuals present with anger. Additionally, anger is likely related to the functions of NSSI and may play a role in maintaining this behavior. Conclusion: Future research is needed to examine the relationship between anger and NSSI utilizing longitudinal designs.

  • Open Access

    The Impact of Intraoperative and Postoperative Analgesic Regimens on Functional Mobility After Lumbar Spine Surgery: A Systematic Review and Meta-analysis

    by Seeley Yoo, Mariana Bouchan, Chelsea Clarke, Gabriella Lozano, Jennifer C. Hall, Emmy Duerr, Emily Luo, Dana G. Rowe, Antoinette Charles, Jacqueline M. Emerson, et al.

    Study Design: Systematic review and meta-analysis. Objective: To assess the efficacy of intraoperative and postoperative analgesic regimens for improving postoperative mobility in patients undergoing lumbar spine surgery (LSS). Summary of Background Data: Mobilization is associated with improved outcomes in patients undergoing LSS. Effective pain management is essential, but there is no standardized analgesic protocol for optimizing mobility after LSS. Understanding the efficacy of various intraoperative and postoperative pain regimens may guide development of such protocols and improve functional outcomes in this population. Methods: A systematic literature search was conducted in MEDLINE, Embase, and Web of Science to query articles investigating the impact of intraoperative and postoperative analgesic regimens on functional mobility in LSS patients. Study characteristics, patient demographics, surgical indications, analgesic interventions, and functional mobility outcomes were extracted. Descriptive statistics and narrative analyses were performed to describe the impact of analgesic strategies on postoperative mobility. A meta-analysis was conducted to investigate the efficacy of intraoperative nerve blocks on reducing postoperative time to ambulation. Results: A total of 4631 studies were screened. Forty-four studies, encompassing 4252 patients, met inclusion criteria. Intraoperative analgesia (spinal and local nerve blocks) was the most common intervention showing significant improvements in postoperative mobility (n=10 studies). A meta-analysis demonstrated that patients who received adjunctive intraoperative analgesia (spinal or local nerve blocks) had significantly reduced time to ambulation compared with controls ( P =0.002). Multimodal medication-based approaches were associated with enhanced functional outcomes and reduced disability scores. Steroid injections and postoperative nerve blocks yielded mixed results. Conclusion: Optimizing postoperative pain interventions is crucial for successful rehabilitation after LSS. Our study emphasizes the benefit of intraoperative nerve blocks as adjuncts to promote early ambulation and functional recovery. Overall, a combination of intraoperative and postoperative therapies may be useful for promoting sustained improvements in mobility.

  • Racial Disparities in Cutaneous Melanoma Mortality: A Systematic Review and Meta-Analysis

    by Caitlin L. Penny, Jamie Lebhar, Beiyu Liu, Krystina Quow, Samantha Kaplan, Cynthia L. Green, Erin B. Lesesky

    Cutaneous melanoma accounts for 5% of new cancer diagnoses in the United States. Despite advancements in treatment of melanoma, marked racial, ethnic, and socioeconomic disparities persist. To determine if there are racial and ethnic disparities in melanoma survival and to highlight opportunities for interventions to improve melanoma patient outcomes. The databases PubMed/Medline, EMBASE, and Web of Science were searched from inception to February 9, 2021. Original publications reporting mortality statistics by race/ethnicity for patients with cutaneous melanoma, vulvar melanoma, or melanoma metastases were selected. Only experimental studies, observational studies, and research letters, with a study population in the United States were included. This investigation was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Authors performed title and abstract screening, followed by full text review in duplicate. We hypothesized that racial and ethnic minority groups would have worse melanoma mortality outcomes when compared to White patients. Five representative studies with dates ranging from 1992-2015 were selected. The overall hazard ratio (HR) for Black patients vs. White patients was 1.31 (95% confidence interval (CI): 1.09-1.57), indicating that Black patients had a 31% increase in the risk of death as compared to White patients. Asian/Pacific Islander patients also had a 31% increase in the risk of death as compared to White patients (HR 1.31, 95% CI: 1.17-1.46). Hispanic patients had a 9% increase in the risk of death as compared to Non-Hispanic White (HR 1.09, 95% CI: 1.03-1.16). There was no significant difference in risk between American Indian/Alaskan Native and White patients (HR 0.94, 95% CI: 0.57-1.55). Worse melanoma survival outcomes in racial and ethnic minority groups are evidenced by multiple studies. More current investigations of melanoma outcomes in racial and ethnic minorities are necessary to identify and implement measures to narrow the gap in health outcomes. Question: Are there racial and ethnic disparities in melanoma mortality outcomes? The pooled meta-analysis revealed that there are significantly worse melanoma survival outcomes in racial and ethnic minority groups when compared to White patients. The overall HR for Black, Asian/Pacific Islander, and Hispanic patients compared to White patients were 1.31, 1.31, and 1.09, respectively. Meaning: Worse melanoma survival outcomes in racial and ethnic minority groups are evidenced by these meta-analyses.

  • Stroke Risk After Bioprosthetic Aortic Valve Replacement in Aortic Stenosis: Systematic Review and Meta-Analysis

    by Tarek Bou Dargham, Sara Hassani, Brian Mac Grory, Melissa A. Daubert, Dylan Ryan, Tracy Truong, Mohamad B. Moumneh, Samantha J. Kaplan, Wuwei Feng, Nada El Husseini

    BACKGROUND: Stroke is a possible complication after bioprosthetic aortic valve replacement (AVR) for severe aortic stenosis (AS), impacting morbidity and mortality. Accurate estimates of the proportion of individuals who experience stroke within and beyond the periprocedural period after transcatheter AVR (TAVR), surgical AVR, and valve-in-valve (ViV) replacement are essential for management and prognostication. The objective was to determine the proportion of adults aged >18 who experienced an ischemic stroke after bioprosthetic AVR for AS. METHODS: A systematic search of MEDLINE, Embase, and Web of Science was conducted from database inception through March 2024. Studies reporting on stroke rates at least 90 days after bioprosthetic AVR for severe AS, including ViV procedures, and meeting predefined eligibility criteria were included. The pooled proportion of individuals experiencing a stroke was estimated for TAVR and ViV procedures, whereas comparative analyses between TAVR and surgical AVR were performed using mixed-effects models in studies directly comparing both procedures. RESULTS: Twenty-seven studies were included in the native AS treatment cohort, and 5 in the ViV subanalysis. In native AS, the pooled 30-day proportion of individuals who had a stroke after TAVR was 3.0% (95% CI, 2.5–3.9), with different studies reporting major and minor stroke proportions of 1.7% each. At 1 year, all stroke proportion was 5.0% (95% CI, 4.0–6.0), major stroke was 3.0%, and minor stroke was 2.0%. Comparative analysis demonstrated that TAVR was associated with significantly lower odds of all stroke at 30 days compared with surgical AVR (odds ratio, 0.73 [95% CI, 0.57–0.93]). No significant difference in the proportions of individuals who had a stroke was observed in TAVR versus surgical AVR at 1, 2, or 5 years. In the ViV cohort, the pooled 30-day and 1-year all stroke proportion after ViV was 2.0% (95% CI, 1.0–3.0) and 3.0% (95% CI, 2.0–6.0), respectively. CONCLUSIONS: This meta-analysis provides updated estimates of stroke after bioprosthetic AVR for AS, capturing risk beyond the early periprocedural period. Future studies should investigate the causes of long-term stroke post-AVR, the effects of different antithrombotic therapies on the risk of stroke, as well as the potential impact of these procedures on short and long-term cognitive function.


  • Artificial intelligence in rare pediatric solid tumor research and clinical care: A scoping review

    by Mallory F. Happ, Christina V. Lindsay, Chelsea Onyeji, Alexandria L. Soto, Maria G. Harb, Samantha Kaplan, Shawn M. Gomez, Thane Blinman, Elisabeth T. Tracy


  • Open Access

    Insurance Payor Status and Outcomes in Foot and Ankle Surgery

    by Emily J. Luo, Dana G. Rowe, Kevin A. Wu, Aaron D. Therien, Mikhail Bethell, Kwabena Adu-Kwarteng, Sarah Lu, Samantha Kaplan, Samuel B. Adams, Albert Anastasio

    Background/Objectives: The increasing prevalence of foot and ankle procedures in the United States has coincided with rising costs of care, exposing socioeconomic disparities within this area of orthopedics. Insurance payor status is one such factor that can affect the quality and accessibility of medical care and has been implicated in orthopaedic patient outcomes. While previous studies in other fields of orthopaedics have demonstrated an association between insurance status and access to treatment, length of hospital stay, post-operative outcomes and complication rates, no comprehensive review has yet explored this relationship in foot and ankle surgery. Thus, the goal of this study is to examine the association between insurance payor status and outcomes in foot and ankle procedures. Methods: A systematic review of five databases was conducted, focusing on the interplay between insurance coverage and foot/ankle procedures. Included studies reported on insurance payor status and patient outcomes following foot and ankle surgery. Extracted outcomes included time to be seen by a provider, complication and revision rates, post-operative Emergency Department (ED)/Urgent Care utilization, readmission rates, hospital length of stay, pain, functional scores, discharge destinations, return to work/activity, and follow-up. Meta-analyses were performed using the Revman 5.3 software. Studies that did not qualify for meta-analyses were described qualitatively. Results: Of 1401 studies identified, 24 texts met inclusion and exclusion criteria. Across the 24 studies, there were a total of 20,950 patients. Noninsured patients had a 59% higher risk of ED/urgent care utilization within 30 days of surgery compared to insured patients [Risk Ratio (RR) = 1.59, 95% Confidence Interval (CI) = 1.18 to 2.12, p < 0.05]. Privately insured patients were seen 3.65 days earlier than patients with government insurance [95% CI = 2.02 to 5.27, p < 0.0001]. Worker’s Compensation patients had statistically significant findings for poorer outcomes, higher pain scores, and lower functional scores. Similarly, Medicaid patients also fared worse on functional scores and had delayed access to appointments and treatments. Conclusions: Patients without private insurance have worse pain and functional outcomes, delayed access to care, and increased utilization of emergency resources following foot and ankle procedures. It is crucial for providers to be cognizant of these discrepancies when caring for patients. Further research is needed to better understand the nuances of these insurance-related disparities within foot and ankle subspecialties.

  • Length of look-back periods in studies using administrative data: a scoping review

    by Miriam Chisholm, Sricharan Navuluri, Moronke Ogundolie, Matthew Boykin, Sakshi Chopra, Sirajbir Sodhi, Samantha Kaplan, Alexandra Gaviser, Tonia Poteat, Whitney R Robinson, et al.

    Administrative data, including electronic health record (EHR) and claims data, are increasingly used to generate real-world evidence for epidemiologic research. Unlike clinical trials, which assess baseline conditions at the initial visit, observational studies using these data must define an appropriate look-back period to identify baseline characteristics. However, to our knowledge, no established guidelines exist on the optimal length of look-back periods by clinical outcome. We conducted a scoping review, with a lens on methodological studies, to assess the frequency and variability of look-back periods used in epidemiologic studies. We searched PubMed for studies that used look-back periods using EHRs, claims data, or international registries. Our search yielded 262 studies spanning a broad range of clinical outcomes. Look-back periods varied substantially, ranging from 12 hours to 39 years, depending on the clinical outcome. The most common clinical areas included pharmacology, cardiovascular disease, cancer, and health care utilization. Our review underscores the need for tailored look-back periods based on the clinical context; we suggest a one-size-fits-all approach may be inadequate. Research should focus on the impact of look-back periods on less-studied outcomes. This review provides a resource for researchers to make informed decisions on the appropriate look-back periods in epidemiologic studies using administrative data.